Liposomal Amphotericin and Caspofungin: Salvage Therapy for Invasive Aspergillosis in Hepatic Failure

E-ISSN： 2055-2335|38|3|223-225

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.38, Iss.3, 2008-09, pp. : 223-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Caspofungin a salvage therapy contender for aspergillosis

Inpharma, Vol. 1, Iss. 1476, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

A liposomal amphotericin B injection [Amphocil; Samaritan Pharmaceuticals Europe] has received approval in Cyprus, for invasive aspergillosis

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Amphotericin B formulations in invasive aspergillosis

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Caspofungin: A Review of its Use in Oesophageal Candidiasis, Invasive Candidiasis and Invasive Aspergillosis

By Keating G.M. Figgitt D.P.

Drugs, Vol. 63, Iss. 20, 2003-01 ,pp. : 2235-2263

Adis International

Access to resources Recommend Favorite

Liposomal Amphotericin B: A Review of its Use as Empirical Therapy in Febrile Neutropenia and in the Treatment of Invasive Fungal Infections

By Moen Marit D. Lyseng-Williamson Katherine A. Scott Lesley J.

Drugs, Vol. 69, Iss. 3, 2009-02 ,pp. : 361-392

Adis International

Access to resources Recommend Favorite